Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05774899
Title CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Glenn J. Hanna
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field